RecruitingPhase 2Phase 3NCT03951194

Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women

Investigating Improvement of Ovarian Function Following Autologous PRP Intra-ovarian Infusion in Perimenopausal Women

Sponsor

Genesis Athens Clinic

Enrollment

100 participants

Start Date

Jun 13, 2019

Study Type

INTERVENTIONAL

Conditions

Infertility, Female Menstrual Cycle Abnormal Perimenopausal Disorder

Summary

Autologous PRP intra ovarian infusion may improve ovarian response and women's hormonal profile and may promote folliculogenesis in perimenopausal women.

Eligibility

Sex: FEMALEMin Age: 40 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Autologous Platelet Rich Plasma (PRP) intra ovarian infusion and Placebo: Autologous Platelet Free Plasma (PFP) intra ovarian infusion for people with infertility, female, menstrual cycle abnormal, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 40 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.